secwatch.observer — SEC 8-K summary
======================================

Issuer:     Innoviva, Inc. (INVA)
CIK:        0001080014
Form:       8-K
Filed at:   2022-07-20T23:59:59+00:00
Accession:  0001140361-22-026440
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Innoviva closes sale of 750 Class A and 750 Class C units of Theravance Respiratory to Royalty Pharma
--------------------------------------------------------------------------------

- Closed sale of 750 Class A and 750 Class C units of Theravance Respiratory Company, LLC to Royalty Pharma Investments 2019 ICAV.
- Closing date was July 20, 2022, as previously announced on July 13, 2022.
- The seller was Innoviva, Inc. and its wholly-owned subsidiary Innoviva TRC Holdings LLC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1080014/000114036122026440/0001140361-22-026440-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1080014/000114036122026440/ny20004764x2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-026440

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer